Is Beam Therapeutics Inc. (BEAM) a Buy, Sell, or Hold?
Beam Therapeutics Inc.
NASDAQ:BEAM
$30.89 USD
-$0.11 (-0.35%)
- Volume
- 2.01M
- Average Volume
- 2.29M
- Market Capitalization
- $3.18B
- P/E Ratio
- -48.27
- Dividend Yield
- 0.00%
- Price Target
- $41.00
- Year High
- $38.26
- Year Low
- $15.60
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $16.99
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
29
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
46
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 2.12M
BEAM Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
BEAM Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Simon Amy | officer: Chief Medical Officer | 2026-06-30 | S-Sale | 34.73 | 2026-07-02 |
| Evans John M. | director, officer: CEO | 2026-06-30 | M-Exempt | 1.03 | 2026-07-01 |
| Evans John M. | director, officer: CEO | 2026-06-29 | M-Exempt | 0.67 | 2026-07-01 |
| Evans John M. | director, officer: CEO | 2026-06-29 | S-Sale | 35.1336 | 2026-07-01 |
| Evans John M. | director, officer: CEO | 2026-06-30 | S-Sale | 34.2633 | 2026-07-01 |
| Evans John M. | director, officer: CEO | 2026-06-29 | S-Sale | 35.9119 | 2026-07-01 |
| Evans John M. | director, officer: CEO | 2026-06-30 | S-Sale | 34.8437 | 2026-07-01 |
| Evans John M. | director, officer: CEO | 2026-06-29 | M-Exempt | 1.03 | 2026-07-01 |
| Evans John M. | director, officer: CEO | 2026-06-30 | M-Exempt | 1.03 | 2026-07-01 |
| Evans John M. | director, officer: CEO | 2026-06-29 | M-Exempt | 0.67 | 2026-07-01 |
| FMR LLC | 10 percent owner, other: See Remark 1 | 2026-06-25 | S-Sale | 35.12 | 2026-06-29 |
| FMR LLC | 10 percent owner, other: See Remark 1 | 2026-06-26 | S-Sale | 35.26 | 2026-06-29 |
| Ciaramella Giuseppe | officer: President | 2026-06-17 | M-Exempt | 1.03 | 2026-06-22 |
| Ciaramella Giuseppe | officer: President | 2026-06-17 | M-Exempt | 0.67 | 2026-06-22 |
| Ciaramella Giuseppe | officer: President | 2026-06-17 | M-Exempt | 1.03 | 2026-06-22 |
| Ciaramella Giuseppe | officer: President | 2026-06-17 | M-Exempt | 0.67 | 2026-06-22 |
| Shaw Christi | director | 2026-06-03 | A-Award | 29.55 | 2026-06-05 |
| Walsh Kathleen E | director | 2026-06-03 | A-Award | 29.55 | 2026-06-05 |
| MARAGANORE JOHN | director | 2026-06-03 | A-Award | 29.55 | 2026-06-05 |
| Fishman Mark | director | 2026-06-03 | A-Award | 29.55 | 2026-06-05 |
| Guindo Chirfi | director | 2026-06-03 | A-Award | 29.55 | 2026-06-05 |
| COOPER GRAHAM K | director | 2026-06-03 | A-Award | 29.55 | 2026-06-05 |
| Evans John M. | director, officer: CEO | 2026-04-01 | S-Sale | 24.58 | 2026-04-06 |
| Simon Amy | officer: Chief Medical Officer | 2026-04-01 | S-Sale | 24.58 | 2026-04-06 |
| Cavanagh Bethany J | officer: SVP, Finance and Treasurer | 2026-04-01 | S-Sale | 24.58 | 2026-04-06 |
| Bellon Christine | officer: Chief Legal Officer | 2026-04-01 | S-Sale | 24.58 | 2026-04-06 |
| Ciaramella Giuseppe | officer: President | 2026-04-01 | S-Sale | 24.58 | 2026-04-06 |
| Bellon Christine | officer: Chief Legal Officer | 2026-03-31 | A-Award | 0 | 2026-04-02 |
| Cavanagh Bethany J | officer: SVP, Finance and Treasurer | 2026-03-31 | A-Award | 0 | 2026-04-02 |
| Simon Amy | officer: Chief Medical Officer | 2026-03-31 | A-Award | 0 | 2026-04-02 |
| Emany Sravan Kumar | officer: Chief Financial Officer | 2026-03-31 | A-Award | 0 | 2026-04-02 |
| Ciaramella Giuseppe | officer: President | 2026-03-31 | A-Award | 0 | 2026-04-02 |
| Evans John M. | director, officer: CEO | 2026-03-31 | A-Award | 0 | 2026-04-01 |
| Evans John M. | director, officer: CEO | 2026-03-31 | M-Exempt | 0.67 | 2026-04-01 |
| Evans John M. | director, officer: CEO | 2026-03-30 | S-Sale | 22.3692 | 2026-04-01 |
| Evans John M. | director, officer: CEO | 2026-03-31 | S-Sale | 22.7634 | 2026-04-01 |
| Evans John M. | director, officer: CEO | 2026-03-30 | M-Exempt | 0.67 | 2026-04-01 |
| Evans John M. | director, officer: CEO | 2026-03-31 | M-Exempt | 0.67 | 2026-04-01 |
| Ciaramella Giuseppe | officer: President | 2026-02-24 | M-Exempt | 17 | 2026-02-26 |
| Ciaramella Giuseppe | officer: President | 2026-02-24 | M-Exempt | 17 | 2026-02-26 |
| Ciaramella Giuseppe | officer: President | 2026-02-24 | S-Sale | 32.0012 | 2026-02-26 |
| Cavanagh Bethany J | officer: SVP, Finance and Treasurer | 2026-01-31 | A-Award | 27.62 | 2026-02-02 |
| Ciaramella Giuseppe | officer: President | 2026-01-31 | A-Award | 27.62 | 2026-02-02 |
| Emany Sravan Kumar | officer: Chief Financial Officer | 2026-01-31 | A-Award | 27.62 | 2026-02-02 |
| Bellon Christine | officer: Chief Legal Officer | 2026-01-31 | A-Award | 27.62 | 2026-02-02 |
| Evans John M. | director, officer: CEO | 2026-01-30 | M-Exempt | 0.67 | 2026-02-02 |
| Evans John M. | director, officer: CEO | 2026-01-29 | M-Exempt | 0.67 | 2026-02-02 |
| Evans John M. | director, officer: CEO | 2026-01-29 | S-Sale | 29.1925 | 2026-02-02 |
| Evans John M. | director, officer: CEO | 2026-01-30 | S-Sale | 28.2734 | 2026-02-02 |
| Evans John M. | director, officer: CEO | 2026-01-30 | S-Sale | 29 | 2026-02-02 |
| Evans John M. | director, officer: CEO | 2026-01-29 | S-Sale | 29.7428 | 2026-02-02 |
| Evans John M. | director, officer: CEO | 2026-01-31 | A-Award | 27.62 | 2026-02-02 |
| Evans John M. | director, officer: CEO | 2026-01-29 | M-Exempt | 0.67 | 2026-02-02 |
| Evans John M. | director, officer: CEO | 2026-01-30 | M-Exempt | 0.67 | 2026-02-02 |
| Evans John M. | director, officer: CEO | 2026-01-29 | M-Exempt | 0.67 | 2026-02-02 |
| Simon Amy | officer: Chief Medical Officer | 2026-01-31 | A-Award | 27.62 | 2026-02-02 |
| Cavanagh Bethany J | officer: SVP, Finance and Treasurer | 2026-01-22 | S-Sale | 35.0005 | 2026-01-26 |
| Bellon Christine | officer: Chief Legal Officer | 2026-01-22 | S-Sale | 34 | 2026-01-26 |
| Cavanagh Bethany J | officer: SVP, Finance and Treasurer | 2026-01-20 | S-Sale | 30.12 | 2026-01-21 |
| Bellon Christine | officer: Chief Legal Officer | 2026-01-15 | S-Sale | 33.6219 | 2026-01-20 |
| Bellon Christine | officer: Chief Legal Officer | 2026-01-15 | S-Sale | 34.7182 | 2026-01-20 |
| Bellon Christine | officer: Chief Legal Officer | 2026-01-15 | S-Sale | 35.3988 | 2026-01-20 |
| Emany Sravan Kumar | officer: Chief Financial Officer | 2025-12-31 | S-Sale | 27.1 | 2026-01-05 |
| Bellon Christine | officer: Chief Legal Officer | 2025-12-31 | S-Sale | 27.1 | 2026-01-05 |
| Simon Amy | officer: Chief Medical Officer | 2025-12-31 | A-Award | 0 | 2026-01-05 |
| FMR LLC | 10 percent owner, other: See Remark 1 | 2025-10-27 | S-Sale | 26.68 | 2025-10-29 |
| FMR LLC | 10 percent owner, other: See Remark 1 | 2025-10-06 | G-Gift | 0 | 2025-10-08 |
| Cavanagh Bethany J | officer: SVP, Finance and Treasurer | 2025-10-01 | S-Sale | 24.53 | 2025-10-03 |
| Bellon Christine | officer: Chief Legal Officer | 2025-10-01 | S-Sale | 24.53 | 2025-10-03 |
| Evans John M. | director, officer: CEO | 2025-10-02 | M-Exempt | 0.67 | 2025-10-03 |
| Evans John M. | director, officer: CEO | 2025-10-02 | S-Sale | 24.6267 | 2025-10-03 |
| Evans John M. | director, officer: CEO | 2025-10-01 | S-Sale | 24.5062 | 2025-10-03 |
| Evans John M. | director, officer: CEO | 2025-10-01 | M-Exempt | 0.67 | 2025-10-03 |
| Evans John M. | director, officer: CEO | 2025-10-02 | M-Exempt | 0.67 | 2025-10-03 |
| FMR LLC | 10 percent owner, other: See Remark 1 | 2025-07-30 | S-Sale | 20.5 | 2025-08-01 |
| Simon Amy | officer: Chief Medical Officer | 2025-07-01 | S-Sale | 16.9423 | 2025-07-03 |
| Simon Amy | officer: Chief Medical Officer | 2025-07-03 | S-Sale | 20.12 | 2025-07-03 |
| Walsh Kathleen E | director | 2025-06-04 | A-Award | 17.15 | 2025-06-06 |
| Fishman Mark | director | 2025-06-04 | A-Award | 17.15 | 2025-06-06 |
| Shaw Christi | director | 2025-06-04 | A-Award | 17.15 | 2025-06-06 |
| Ho Carole | director | 2025-06-04 | A-Award | 17.15 | 2025-06-06 |
| MARAGANORE JOHN | director | 2025-06-04 | A-Award | 17.15 | 2025-06-06 |
| COOPER GRAHAM K | director | 2025-06-04 | A-Award | 17.15 | 2025-06-06 |
| Guindo Chirfi | director | 2025-06-04 | A-Award | 17.15 | 2025-06-06 |
| FMR LLC | 10 percent owner, other: See Remark 1 | 2025-03-31 | 0 | 2025-04-10 | |
| FMR LLC | 10 percent owner, other: See Remark 1 | 2025-03-31 | 0 | 2025-04-10 | |
| FMR LLC | 10 percent owner, other: See Remark 1 | 2025-03-31 | 0 | 2025-04-10 | |
| Bellon Christine | officer: Chief Legal Officer | 2025-04-01 | S-Sale | 18.3507 | 2025-04-03 |
| Evans John M. | director, officer: CEO | 2025-04-01 | S-Sale | 18.3506 | 2025-04-03 |
| Ciaramella Giuseppe | officer: President | 2025-04-01 | S-Sale | 18.3506 | 2025-04-03 |
| Cavanagh Bethany J | officer: SVP, Finance and Treasurer | 2025-04-01 | S-Sale | 18.3516 | 2025-04-03 |
| Simon Amy | officer: Chief Medical Officer | 2025-04-01 | S-Sale | 18.3506 | 2025-04-03 |
| Simon Amy | officer: Chief Medical Officer | 2025-04-02 | S-Sale | 17.7308 | 2025-04-03 |
| Bellon Christine | officer: Chief Legal Officer | 2025-03-31 | A-Award | 0 | 2025-04-02 |
| Simon Amy | officer: Chief Medical Officer | 2025-03-31 | A-Award | 0 | 2025-04-02 |
| Ciaramella Giuseppe | officer: President | 2025-03-31 | A-Award | 0 | 2025-04-02 |
| Cavanagh Bethany J | officer: SVP, Finance and Treasurer | 2025-03-31 | A-Award | 0 | 2025-04-02 |
| Evans John M. | director, officer: CEO | 2025-03-31 | A-Award | 0 | 2025-04-02 |
| Evans John M. | director, officer: CEO | 2025-01-30 | M-Exempt | 0.67 | 2025-04-02 |
| Evans John M. | director, officer: CEO | 2025-01-30 | M-Exempt | 0.67 | 2025-04-02 |